PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
29-Oct-2025 Enzene Wins CPHI Manufacturing Excellence Award Enzene
29-Oct-2025 Biotechnology in APAC: in-cosmetics Asia spotlights a market predicted to surge in-cosmetics Asia
29-Oct-2025 UCB to unveil new data for RYSTIGGO®▼and ZILBRYSQ®▼ for gMG at the 2025 AANEM Annual Meeting and MGFA Scientific Session UCB
29-Oct-2025 Armata AP-SA02 shows promise for SAB in Phase IIa trial, underscoring growing potential of phage therapy, says GlobalData Armata Pharmaceuticals
29-Oct-2025 Amerigo Scientific Unveils Active Venom Peptides to Power Up Cosmetic Product Research and Development Amerigo Scientific
29-Oct-2025 BOC Sciences Integrates Its Glycan Technique Portfolio Into a New Hub BOC Sciences
29-Oct-2025 Lifeasible Upgrades Its Forestry Tissue Culture Platform to Advance Sustainable Tree Propagation Lifeasible
29-Oct-2025 Creative BioMart Launches Enhanced Protein Phylogenetic Analysis Service to Deepen Evolutionary Insight Creative BioMart
28-Oct-2025 NICE recommends Bayer’s Nubeqa® (darolutamide) plus androgen deprivation therapy as a treatment option for patients with hormone-sensitive metastatic prostate cancer Bayer
28-Oct-2025 ViiV Healthcare launches ‘Risk to Reasons’ initiative in the UK to empower women to take control of their HIV prevention choices ViiV Healthcare
28-Oct-2025 Lundbeck and OpenAI join forces to unlock innovation and boost productivity Lundbeck, OpenAI
28-Oct-2025 BIMZELX® (bimekizumab-bkzx) three year rheumatology data at ACR 2025 demonstrated sustained inflammation control in psoriatic arthritis and axial spondyloarthritis UCB
28-Oct-2025 Biobeat report predicts CDMOs in China & USA to see fastest growth – with mAbs, PROTACs, ADCs & sterile filling in demand Biobeat
28-Oct-2025 ViCentra Strengthens Leadership Team to Accelerate Growth ViCentra
28-Oct-2025 Domain Therapeutics Doses First Patients in Phase I/II Trial of DT-7012 Targeting CCR8 in Solid Tumors Domain Therapeutics
27-Oct-2025 Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis Levicept
27-Oct-2025 Adaptam Therapeutics raises €3 million to pioneer cancer immunotherapies against immunosuppressive myeloid cells Andrew Lloyd Associates
24-Oct-2025 Personalized Medicine Biomarkers Market 2025–2033: Trends, Growth Drivers, and Market Size Forecast to USD 72.06 Billion Acumen Research And Consulting
23-Oct-2025 Syngene International announces plans to add bioconjugation suite for end-to-end Antibody-Drug Conjugates Development Syngene
23-Oct-2025 Elixion Biotech validates its quantum-informed R&D process, proving readiness to advance precision medicines Elixion Biotech